MNLO Overview
Upcoming Projects (MNLO)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (MNLO)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (MNLO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (MNLO)
-
Menlo Therapeutics Begins Phase 2 Clinical Trial of Serlopitant for Pruritus Associated with Psoriasis
Ticker: MNLO
Occurred on: Nov 21, 2017 -
Results Presented from Menlo Therapeutics'(MNLO) TCP-101 Phase 2 Study at the 2017 EADV conference
Ticker: MNLO
Occurred on: Sep 18, 2017 -
Results Presented from Menlo Therapeutics'(MNLO) Phase 2 Serlopitant Trial (TCP-102) in 127 Subjects With Prurigo Nodularis
Ticker: MNLO
Occurred on: Mar 08, 2017
Strategic Initiatives (MNLO)
-
Foamix Pharmaceuticals (FOMX) becomes a wholly owned subsidiary of Menlo Therapeutics (MNLO)
Tickers: MNLO, FOMX
Announcement Date: Mar 09, 2020
